Current Report · Items 3.01, 9.01 · 8-K
Aditxt, Inc.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 6, 2026. as previously reported in a Current Report on Form 8-K filed by Aditxt, Inc.…
Filed Jun 24, 2026Accepted Jun 24, 2026, 11:36 AM EDTCIK 1726711Accession 0001213900-26-071380
Company context
Aditxt, Inc. (NASDAQ: ADTX) is a public company focused on developing and commercializing health innovation platforms. Ignite Proteomics is currently a 100%-owned subsidiary of Aditxt. Through the proposed business combination, Aditxt expects to unlock value in Ignite at an implied equity value of approximately $150 million, while Ignite is expected to become an independent publicly traded company. Aditxt is expected to continue as a separate Nasdaq-listed public company, subject to continued compliance with Nasdaq listing requirements.
Current securities
Historical securities (2)
Registered securities in this filing
ADITXT, INC. · 8-K · Filed 2026-06-24
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.001 per share
- Symbol
- ADTX
- Exchange
- NASDAQ
- Classification
- COMMON
Filing context
Context: AsOf2026-06-23
Dimensions: Not supplied
Accession 000121390026071380 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 3.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.01Item 3.01 - Notice of Delisting
Item 3.01. Notice of Delisting or Failure
to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On May 6, 2026. as previously reported in a Current
Report on Form 8-K filed by Aditxt, Inc. (the “Company”) on May 8, 2026, the Company received formal notice (the “May
6th Letter”) from the Staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market
LLC (“Nasdaq”) that Nasdaq Staff had determined to delist the Company’s securities from Nasdaq. In the May 6th Letter, the Staff stated that the bid price of the Company’s listed securities had closed at less than $1.00 per share over the
previous 30 consecutive business days, from March 24, 2026 through May 5, 2026, and that, as a result, the Company is not in compliance
with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share (the “Bid
Price Rule”). The Staff further stated in the May 6th Letter that, although companies are typically afforded a 180-calendar
day period to regain compliance with the Bid Price Rule, the Company is not eligible for any such compliance period pursuant to Nasdaq
Listing Rule 5810(c)(3)(A)(iv). The Staff cited the fact that the Company has effected a reverse stock split over the prior one-year period
and has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one.
On May 27, 2026, as previously reported in a Current
Report on Form 8-K filed by the Company on May 29, 2026, the Company received an additional formal notice (the “May 27th Letter”) from the Staff notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s
Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum
stockholders’ equity requirement of $2,500,000 for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’
Equity Requirement”). The May 27th Letter further notes that the Company does not presently satisfy either of the alternative
continued listing standards under Nasdaq Listing Rule 5550(b) - a market value of listed securities of $35 million or net income
from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed
fiscal years (such non-compliance, the “Stockholders’ Equity Deficiency”). The May 27th Letter states that
the Stockholders’ Equity Deficiency serves as an additional basis for delisting the Company’s securities from Nasdaq, and
that the Nasdaq Hearing Panel (the “Panel”) will consider the Stockholders’ Equity Deficiency, together with the matters
that were the subject of the May 6th Letter, in rendering its determination regarding the Company’s continued listing
on Nasdaq.
The Company timely requested a hearing, which
stayed the delisting and suspension of the Company’s securities pending the decision of the Panel. A hearing on the matter was held
on June 11, 2026.
On June 23, 2026, the Panel notified the Company
(the “Notice”) that the Panel has determined to deny the Company’s request to continue its listing on Nasdaq and that
trading in the Company’s common stock will be suspended at the open of trading on June 25, 2026.
The Company may request that Nasdaq Listing and
Hearing Review Council review the decision of the Panel within 15 days of the Company’s receipt of the Notice.
A copy of the Notice is attached to this report
as Exhibit 99.1
This report contains forward-looking statements,
including, but not limited to, the Company’s ability to maintain its listing on Nasdaq and the Company’s ability to have the
Panel’s decisions overturned by the Nasdaq Listing and Hearing Review Council. Such statements are subject to risks and uncertainties,
and actual results may differ materially from those expressed or implied by such forward-looking statements. Investors are cautioned not
to place undue reliance on these forward-looking statements, which speak only as of the date of this report. The Company undertakes no
obligation to update any forward-looking statement in this report, except as required by law.
Filed exhibits (1)
EX-99.1 (by filename) ea029578801ex99-1.htmEX-99.1
2
ea029578801ex99-1.htm
NASDAQ HEARINGS PANEL NOTICE, DATED JUNE 23, 2026
Exhibit 99.1
Sent via electronic delivery
June 23, 2026
Keely Moxley
Donohoe Advisory Associates LLC
9801 Washingtonian Blvd Ste 340
Gaithersburg, MD 20878
RE: Aditxt, Inc. (Symbol: ADTX)
Nasdaq Listing Qualifications Hearings
Docket No. NQ 7352C-26
Dear Ms. Moxley:
The Nasdaq Hearings Panel (the “Panel) has
determined to deny the request of Aditxt, Inc. (the “Company”) to continue its listing on The Nasdaq Stock Market (“Nasdaq”
or the “Exchange”) subject to the conditions described below. Trading in the Company’s common stock will be suspended
at the open of trading on June 25, 2026.
In making its decision, the Panel considered the
entire record, which is incorporated by reference into this decision. Background information about the Company, including its business
description, financial information, market data and compliance history is set forth in the Listing Qualifications Staff’s June 4,
2026 memo to the Panel. The Company had the opportunity to correct anything it believed to be inaccurate in that memo. A hearing on this
matter was held on June 11, 202…
Open exhibit ↗